Why Did W.H.O. Delay Declare Congo Ebola Emergency?

By VirentaNews Staff — May 18, 2026

In the dense, humid forests of the northern Equateur province, where rivers twist like serpents through isolated villages, the first whispers of illness began in late May. A local healer fell suddenly ill—feverish, vomiting, bleeding from the gums. By the time health workers arrived, three others had died under similar circumstances. The air in the clinics grew thick with fear. Blood samples were drawn and sent to Kinshasa, then to specialized labs abroad. But the tests came back inconclusive. The virus was elusive, not matching known strains of Ebola. In this remote corner of the Democratic Republic of the Congo, where roads vanish in the rainy season and medical infrastructure is skeletal, a silent incubation was underway. The pathogen, later confirmed as the rare Bombali species of Ebola virus, was spreading beneath the radar of even the most advanced surveillance systems.

Outbreak Confirmed, Response Delayed

The World Health Organization (WHO) did not declare a public health emergency until early July, more than five weeks after the initial cases were reported to national authorities. During that time, at least 28 people were infected, including six healthcare workers, and 14 have died. The delay stemmed from difficulties in confirming the virus: the Bombali strain, first identified in bats in 2018, had never before caused a documented human outbreak. Standard Ebola diagnostic kits failed to detect it, leading to false negatives and confusion. Only after genomic sequencing at the Institut National de Recherche Biomédicale in Kinshasa—and confirmation by the U.S. Centers for Disease Control and Prevention—was the true nature of the threat understood. An American doctor working with an international aid group in Mbandaka has since been confirmed infected and is being treated in a high-containment facility in Uganda, marking the first known cross-border transmission.

Years of Preparedness, but Gaps Remain

The DRC has endured 14 Ebola outbreaks since 1976, more than any other nation, and developed a robust response protocol after the devastating 2018–2020 Kivu outbreak that killed over 2,200. Mobile labs, ring vaccination with the rVSV-ZEBOV vaccine, and community engagement strategies were all deployed swiftly in theory. But the Bombali strain exposed a critical vulnerability: the country’s surveillance network relies heavily on known pathogens. When a novel or rare variant emerges, the system falters. In 2018, scientists from Columbia University and the WHO’s PREDICT project discovered Bombali virus in Angolan free-tailed bats, warning it had the potential to spill over into humans. Yet no diagnostic tools or vaccines were developed in anticipation. As one WHO epidemiologist admitted in a private briefing, “We prepared for the last war, not the next one.”

The Frontline Responders

Now, a new generation of health workers—many survivors of past outbreaks—are racing to contain the crisis. Dr. Mireille Mpaka, a Congolese epidemiologist who lost her brother in the 2018 outbreak, leads contact tracing in Equateur. “We know the patterns,” she said in an interview, “but this virus moves differently. People don’t always show bleeding symptoms early. They think it’s malaria.” International teams from Médecins Sans Frontières and the CDC have bolstered testing and isolation units, but mistrust lingers. In villages where rumors claim Ebola is a government hoax or a foreign experiment, patients hide their sick. The American doctor, whose identity has not been released, contracted the virus while treating a patient misdiagnosed with typhoid. Colleagues say he delayed seeking care, fearing stigma. His case underscores the risks faced by healthcare providers operating in diagnostic gray zones.

Regional and Global Implications

The outbreak has already strained regional health systems. Uganda, Rwanda, and the Central African Republic have heightened border screenings, and the African Union has convened an emergency health summit. The economic toll in the DRC could be severe, with trade disruptions and travel advisories looming. More concerning is the precedent: if rare or emerging viral strains can evade detection for weeks, the global health architecture may need a fundamental overhaul. The Coalition for Epidemic Preparedness Innovations (CEPI) has called for broader-spectrum vaccines, while the WHO is revisiting its emergency declaration criteria. For now, over 400 contacts are under observation, and a new rapid test capable of detecting multiple Ebola species is being fast-tracked for deployment.

The Bigger Picture

This outbreak is not just a medical crisis but a warning about the fragility of pandemic preparedness. Climate change, deforestation, and human encroachment into wildlife habitats are increasing the frequency of zoonotic spillovers. Viruses once confined to animal reservoirs are adapting. The Bombali strain’s emergence in humans suggests the next major outbreak may not come from a known pathogen but from one we’ve barely studied. As scientists at Nature warned in 2018, “The question is not if, but when.”

What comes next will test both science and solidarity. Can the global health community pivot from reactive measures to proactive surveillance? Will funding follow the warnings of virologists, or wait for higher death tolls? In the villages of Equateur, where mourning rituals are silenced and children avoid touching their elders, the cost of delay is already measured in graves. The world may have missed the first pulse of this outbreak—but it must not miss the lesson.

Source: The New York Times